Category: Science


MRA’s Young Investigator Program: Bringing New Talent & Novel Ideas for Research Forward

By Pamela Goldsmith, MRA Director of Communications | 28 February 2017 In Events, Science

In February, at the Ninth Annual MRA Scientific Retreat, a Young Investigator Breakfast brought together scores of past and current MRA Young Investigators where I connected with one of MRA’s first young investigators, Dr. Timothy Bullock.

Read More


The Power of Combination Therapies: One Patient’s Road to Remission

By Pooja H. Rambhia, MD Candidate, Case Western Reserve University | 28 February 2017 In Science, Treatment

Metastatic melanoma can be a devastating diagnosis to receive. Just hearing the word cancer for most is terrifying. While the fear is understandable, today new targeted therapies and immunotherapies are delivering new hope for many.

Read More


Melanoma Immunotherapy and Precision Medicine — a Medical Student’s Perspective

By Pooja H. Rambhia, MD Candidate, Case Western Reserve University | 20 January 2017 In Science

Malignant melanoma research has provided the perfect opportunity to explore the intersection of immunotherapy and precision medicine, which has greatly transformed melanoma therapeutics in the last decade.

Read More


Parallels between Disease States

By Michael Kaplan, MRA President & CEO | 30 November 2016 In Science

Six months ago I was offered the opportunity to serve as President & CEO of MRA and in July, I officially began. For the past 24 years, I’ve worked in the HIV field and am struck by the many parallels that exist between my past work and melanoma.

Read More


Understanding Immunotherapy Part 3: CTLA-4

By Amrita Bhatt, MRA Intern | 15 June 2016 In Science, Treatment

Now that you’ve read our background on immunotherapy and learned about PD-1, it’s time to focus on another protein that plays a key role in cancer development, CTLA-4. What is CTLA-4? In addition to displaying PD-1 on the cell surface, T cells also display CTLA-4.

Read More


Research Q&A: Dr. Tim Bullock

21 March 2016 In Science

In the latest blog post, we chatted with the University of Virginia’s Tim Bullock, Ph.D., a tumor immunologist in the Pathology Department and MRA-funded investigator. Read on to learn what he has to say about melanoma research and prevention efforts.

Read More


Understanding Immunotherapy Part 2: PD-1

By Amrita Bhatt, MRA Intern | 17 February 2016 In Science, Treatment

Now that we’ve provided a brief background on immunotherapy, it’s time to dive more deeply into the subject. In the second installment of this blog series, we’ll be examining PD-1, a protein that plays a crucial role in cancer’s ability to hide from our immune systems. What is PD-1? PD-1...

Read More


Researcher Q&A: Dr. John D’Orazio

7 January 2016 In Science

In the latest blog post, we chatted with the University of Kentucky’s John D’Orazio, M.D., Ph.D., a pediatric hematologist oncologist, and a 2015 MRA grant awardee. Read on to learn what he has to say about melanoma research and prevention efforts.

Read More


Researcher Q&A: Dr. Vashisht Yennu Nanda

3 December 2015 In Science

MD Anderson\'s Dr. Yennu Nando explains his research for melanoma.

Read More


Login

×